BPG is committed to discovery and dissemination of knowledge
Citation
Zheng HZ, Wang P, Zheng HJ, Wang ZQ, Li QX, Chen HW, Chen HQ, Lei QC. Urinary N1, N12-diacetylspermine as a potential tumor biomarker for gastric and colorectal cancer. World J Gastroenterol 2026; 32(33): 118185 [DOI: 10.3748/wjg.118185]
Comments (1)
Andrzej S Tarnawski, MD, PhD, Professor September 08, 2026, 08:53
Zheng et al. evaluated the diagnostic value of urinary N1N12-diacetylspermine (DiAcSpm) in gastric cancer (GC) and colorectal cancer (CRC). The study analyzed 209 urine samples and compared DiAcSpm's diagnostic performance with CEA and CA19-9. The results suggest that DiAcSpm is elevated in GC and CRC patients and that a combination with CEA improves diagnostic sensitivity. If confirmed in a larger sample, it could be clinically important.
Please LOGIN to submit a new comment.